Navigation Links
Kevin Kruse Named Executive Director of the Society of Pharmaceutical and Biotech Trainers

ROANOKE, Va., Sept. 23 /PRNewswire-USNewswire/ -- The Society of Pharmaceutical and Biotech Trainers (SPBT) today announced that Kevin Kruse has been named the new executive director, effective October 1.  He brings to his new role significant life science training experience and strong entrepreneurial expertise.  

Mr. Kruse will be responsible for leading the operations and educational services of SPBT, a non-profit organization that represents more than 1,000 members in the training profession from pharmaceutical, biotech, medical device and diagnostic companies.  For the last 20 years, Mr. Kruse has dedicated his career to determining the most effective ways to design and deliver health-related education and training.

"Kevin is an experienced and passionate advocate for the training industry and he understands the impact that our organization has on the profession as well as the individual careers of our members," said SPBT Board President Mike Capaldi.  "Kevin has an impressive portfolio of training expertise and we are pleased to have his leadership at SPBT."

Mr. Kruse is the founder of several life science training and communication companies including ACI, Kenexa and AXIOM. Most recently, he served as founder and president of KRU Research, a media-consultancy serving life science marketers and healthcare educators. His organizations have been recognized with numerous awards including Inc 500 and Best Place to Work in Pennsylvania.  Mr. Kruse has also been named one of the "Top 100 Most Inspiring People in the Life Science Industry" by PharmaVoice.  He has written or contributed to numerous books including: Technology-based Training: The Art and Science of Design, Development, and Delivery; What Smart Trainers Know; Active Training; and We: Driving Full Engagement for Performance and Profits.

Mr. Kruse succeeds Brian Fagan, who has announced his retirement after serving as executive director for 13 years.


The Society of Pharmaceutical and Biotech Trainers (SPBT) is a worldwide 501©3 nonprofit organization dedicated to supporting trainers at pharmaceutical, biotech, medical device, and diagnostic companies. SPBT provides resources to help trainers excel, personally and professionally. The organization also aims to reinforce the valuable contributions that trainers bring to their companies.

SPBT was established in 1971 and originally named the National Society of Pharmaceutical Sales Trainers. Today, SPBT has a membership of more than 1,000 trainers employed by over 240 pharmaceutical, biotech, medical device, and diagnostic companies around the globe.

SOURCE Society of Pharmaceutical and Biotech Trainers
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Verenium Appoints Kevin Bracken Vice President of Manufacturing
2. Sanford Rose Associates(R)-Rochester Named Top Office
3. Novo Nordisk Named a 2010 Working Mother 100 Best Company
4. AlloSource Named One of Colorados Top Three Healthcare Companies
5. Medicago named in Presidential report on meeting the challenges of pandemic influenza
6. maxIT Healthcare Named to Inc. 5000 List
7. BioPharm Systems Named to the 2010 Inc. 500
8. 5000 List of Fastest-Growing Companies in the U.S.
9. Bill Gates Named Keynote Speaker at the 2010 mHealth Summit
10. NeoStem Named Best Stem Cell Company in The New Economys 2010 Biotech Awards
11. Arteriocyte Named Top Biotech Start Up Venture by the Ohio Venture Association for 2010
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... company uBiome, were featured on AngelList early in their initial angel funding process. ... AngelList syndicate for individuals looking to make early stage investments in the microbiome ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
(Date:11/24/2015)... , November 24, 2015 ... market research report "Oligonucleotide Synthesis Market by Product & ... Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & ... by MarketsandMarkets, the market is expected to reach USD ... 2015, at a CAGR of 10.1% during the forecast ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/12/2015)... , Nov. 11, 2015   Growing ... reliable analytical tools has been paving the way ... qualitative determination of discrete analytes in clinical, agricultural, ... are being predominantly used in medical applications, however, ... environmental sectors due to continuous emphasis on improving ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):